Advertisement

Topics

New CAR-T drug for leukemia, while effective, is ‘going to cost a fortune’

10:43 EDT 23 Aug 2017 | STAT

When doctors talk about a new leukemia drug from Novartis, they ooze enthusiasm, using words like “breakthrough,” “revolutionary,” and “a watershed moment.” But when they think about how much the therapy…

Original Article: New CAR-T drug for leukemia, while effective, is ‘going to cost a fortune’

NEXT ARTICLE

More From BioPortfolio on "New CAR-T drug for leukemia, while effective, is ‘going to cost a fortune’"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...